D30E (p.Asp30Glu) variant of ANK2 (Ankyrin-2)

D30E (p.Asp30Glu) in ANK2 (Ankyrin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data, experimental measurements, and structural context.

D30E (p.Asp30Glu) variant details